Novian Health

  • About Us
    • Overview
    • Management
    • Board Of Directors
    • Investors
  • Research & Products
    • Novilase® Breast Therapy
    • Clinical Trials & Registries
    • Publications
    • Intellectual Property
  • News
    • News & Press Releases
    • Media Coverage
    • Upcoming Events
  • Contact
    • Careers

NEWS & PRESS RELEASES

2022 2021 2020 2019 2015 2014 2013 2012 2011
2022
  • Novian Health Earns New Product Innovation Award for Novilase Breast Therapy (6 December 2022)
2021
  • Novian Health Gains FDA Breakthrough Designation for Novilase Breast Therapy (28 September 2021)
  • Novian Health Inc. Announces the Second Close of Convertible Note Financing (23 August 2021)
  • Novian Health Inc. Announces the First Close of Convertible Note Financing (28 July 2021)
  • Novian Health to Present at the Cavendish Global Summit on February 25, 2021 (12 February 2021)
2020
  • Novian Health Chosen As One of the Top 50 MedTech Startups Transforming the Healthcare Industry (23 September 2020)
  • Novian Health Adds Healthcare Leader Stephen Bonner to Board of Directors (09 September 2020)
  • MedTech Innovator Announces Top 50 Medtech Startups Selected for Annual Showcase and Accelerator (22 June 2020)
2019
  • UK's Daily Mail Profiles One of the First Patients in Britain to Have Novilase Procedure (30 September 2019)
  • Novian Health Obtains CE Mark for Novilase Breast Therapy (16 July 2019)
  • Novian Health Chosen as Red Herring Top 100 North America Winner (05 June 2019)
2015
  • Breast Cancer Clinical Trial of Laser Ablation Treatment Shows Promising Results for Patients (10 Dec 2015)
2014
  • Novian Health President & CEO Interviewed by Med Device Insights
  • Walter Reed Bethesda Joins Novilase Clinical Trial (9 Sept 2014)
  • Novian Health Wins Acclaim from Frost & Sullivan for Novilase Interstitial Laser Ablation Therapy for Early-Stage Malignant Breast Tumors (2 Sept 2014)
  • Novian Health Named Finalist for the 2014 Red Herring Top 100 North America Award (16 May 2014)
2013
  • Novian Health Awarded New Patent for Breast Cancer Treatment Technology (05 Dec 2013)
  • Novian Health Venture Capital Activity in 1Q 2013 for Breast Cancer Clinical Trials (18 April 2013)
  • Novian Health Closes $11 Million in Funding for Breast Cancer Clinical Trials (04 Feb 2013)
2012
  • Novian Health Begins Breast Cancer Clinical Trial (12 April 2012)
2011
  • Novian Health Founder Is Honored as Breast Cancer Leader by Chicago Komen Affiliate (20 Oct 2011)
  • Novian Health Awarded New Patent for Breast Tumor Treatment Technology (28 Sept 2011)
  • Novian Health Receives FDA Approval to Study Breast Cancer Therapy (14 July 2011)

ARCHIVES

MEDIA COVERAGE

NBC Denver 9NEWS Groundbreaking Breast Cancer Laser Treatment Novilase® (15 Dec 2015)

WABC 7 New York - Promising Research & Options in Breast Cancer
(10 Oct 2015)

NBC Denver 9NEWS Coverage on the Novilase® Clinical Trial at Rose Medical Center (10 Oct 2013)

WGN 9News Chicago – Novilase Breast Therapy for Benign Tumors (2007)

CBS Highlights New Laser Treatment being studied for Breast Cancer (2001)

UPCOMING EVENTS

 

 

CONTACT US

Novian Health Inc.
(Headquarters)
Novian Health Inc.
(Manufacturing)
222 W Merchandise Mart Plaza
Suite 1230
Chicago, Illinois 60654
1205 E State Avenue
Tonganoxie, KS 66086
Office: 312-266-7200 Office: 312-266-7200
Fax: 312-266-7202 Fax: 312-266-7202
Email: info@novianhealth.com Email: info@novianhealth.com

    

LATEST NEWS

  • Novian Health Earns New Product Innovation Award for Novilase Breast Therapy (6 December 2022)
  • Novian Health Gains FDA Breakthrough Designation for Novilase Breast Therapy (28 September 2021)
  • Novian Health Inc. Announces the Second Close of Convertible Note Financing (23 August 2021)
  • Novian Health Inc. Announces the First Close of Convertible Note Financing (28 July 2021)
  • Novian Health to Present at the Cavendish Global Summit on February 25, 2021 (12 February 2021)

Copyright © 2023 Novian Health. All Rights Reserved. Powered by